'Profound efficacy' for the Vir-GSK COVID-19 vaccine prompts EUA talk while Roche-Gilead fails

Retrieved on: 2021-03-11 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

'Profound efficacy' for the Vir-GSK COVID-19 vaccine prompts EUA talk while Roche-Gilead fails. View article details on hiswai:

Excerpt

Meanwhile, the phase III study of Actemra/RoActemra (tocilizumab) plus Veklury (remdesivir) vs. placebo plus Veklury, from Roche Holding AG and ...

Article found on: www.bioworld.com